Date: 2014-06-30
Type of information: Services contract
Compound: HiSeq 2500 and consumables to develop and perform non-invasive prenatal testing (NIPT)
Company: Illumina (USA - CA) The Center for Human Genetics and Laboratory Diagnostics Martinsried (Germany)
Therapeutic area: Technology - Services
Type agreement: services
Action mechanism:
Disease:
Details: * On June 30, 2014, Illumina announced that it has entered into an agreement with the Center for Human Genetics and Laboratory Diagnostics Martinsried, under which they will use the HiSeq 2500 and consumables from Illumina to develop and perform non-invasive prenatal testing (NIPT). The Center for Human Genetics and Laboratory Diagnostics will offer NIPT in Germany.
Financial terms:
Latest news:
